Olifant Lerato Lucia, Phalane Edith, Phaswana-Mafuya Refilwe Nancy
Faculty of Health Sciences, South African Medical Research Council/University of Johannesburg (SAMRC/UJ) Pan African Centre for Epidemics Research (PACER) Extramural Unit, Johannesburg 2006, South Africa.
Methods Protoc. 2024 Sep 29;7(5):77. doi: 10.3390/mps7050077.
Although South Africa was the first country to register and roll out oral pre-exposure prophylaxis (PrEP) biomedical human immunodeficiency virus (HIV) prevention intervention in sub-Saharan Africa (SSA), its uptake remains low, particularly among adolescent girls and young women (AGYW). The uptake of PrEP may have worsened during the Coronavirus disease 2019 (COVID-19) pandemic. Some innovative interventions to improve PrEP uptake among AGYW have been implemented. This study aims to evaluate the effectiveness of PrEP innovative interventions implemented during COVID-19 towards reducing the risk of HIV infection among AGYW in South Africa. An exploratory, descriptive design will be conducted to carry out four study objectives. Firstly, to carry out a systematic review of innovative PrEP interventions implemented during COVID-19 in SSA countries. Secondly, to conduct a stakeholder analysis to identify PrEP stakeholders and interview them on their views on the implemented interventions. Thirdly, to assess the implementation outcomes of the innovative interventions using document reviews and Consolidated Framework for Implementation Research. Fourthly, to develop a framework for an improved PrEP service delivery among AGYW. Qualitative data will be captured in ATLAS.ti software (Technical University, Berlin, Germany) version 23 and analysed via thematic analysis. A statistical software package (STATA) version 18 (College Station, TX, USA) will be used to capture quantitative data and analyse them via descriptive analysis. The generated evidence will be used towards the development of framework, guidelines, and policies to strengthen the uptake of, scale-up, and adherence to PrEP among AGYW.
尽管南非是撒哈拉以南非洲地区(SSA)首个注册并推广口服暴露前预防(PrEP)这一生物医学艾滋病毒(HIV)预防干预措施的国家,但其接受度仍然很低,尤其是在少女和年轻女性(AGYW)中。在2019年冠状病毒病(COVID-19)大流行期间,PrEP的接受度可能进一步恶化。已经实施了一些创新干预措施来提高AGYW对PrEP的接受度。本研究旨在评估在COVID-19期间实施的PrEP创新干预措施对降低南非AGYW感染HIV风险的有效性。将采用探索性描述性设计来实现四个研究目标。首先,对SSA国家在COVID-19期间实施的创新PrEP干预措施进行系统综述。其次,进行利益相关者分析,以确定PrEP利益相关者,并就他们对已实施干预措施的看法进行访谈。第三,使用文件审查和实施研究综合框架评估创新干预措施的实施结果。第四,为改善AGYW的PrEP服务提供制定一个框架。定性数据将在ATLAS.ti软件(德国柏林技术大学)23版中收集,并通过主题分析进行分析。将使用统计软件包(STATA)18版(美国得克萨斯州大学城)收集定量数据,并通过描述性分析进行分析。所产生的证据将用于制定框架、指南和政策,以加强AGYW对PrEP的接受度、扩大规模并提高依从性。